← LeaderboardsInvestigatorsiAttributed = a PI's even-split share of each grant — a $1M grant with 2 PIs counts $500K each.
Aleutian Therapeutics, Inc.
Los Angeles, CA
$985,013
Total funding
3
Grants
Funding mix
By agency
NIH$985,013 · 3
By mechanism
R41$985,013 · 3
Investigators at Aleutian Therapeutics, Inc.
InvestigatorsiAttributed = a PI's even-split share of each grant — a $1M grant with 2 PIs counts $500K each.
Exposure= the full size of every grant they're on ($1M each).
Rising Stars
First grant in the last 5 yrs
Emerging Leaders
6–10 yrs in
Not enough data
All-Time
Most funded here, all years
Largest grants
Development of an immune evasive stem cell line for Type 1 diabetes regenerative therapy$372,067
R41 · FY2025 · DK
Development of immune evasive strategies for allogeneic cell replacement therapies$307,091
R41 · FY2025 · AI
Development of a gene edited platform to enable human allogeneic cell replacement therapy$305,855
R41 · FY2025 · AI